Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Myasthenia gravis
ADR ID BADD_A02913
ADR Hierarchy
10      Immune system disorders
10.04      Autoimmune disorders
10.04.05      Muscular autoimmune disorders
10.04.05.001      Myasthenia gravis
15      Musculoskeletal and connective tissue disorders
15.05      Muscle disorders
15.05.08      Myasthenia gravis and related conditions
15.05.08.001      Myasthenia gravis
17      Nervous system disorders
17.05      Neuromuscular disorders
17.05.04      Neuromuscular junction dysfunction
17.05.04.001      Myasthenia gravis
Description A disorder characterized by weakness and rapid fatigue of any of the skeletal muscles. [CTCAE] A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine receptors damage the motor endplate portion of the NEUROMUSCULAR JUNCTION, impairing the transmission of impulses to skeletal muscles. Clinical manifestations may include diplopia, ptosis, and weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles. THYMOMA is commonly associated with this condition. (Adams et al., Principles of Neurology, 6th ed, p1459) [MeSH]
MedDRA Code 10028417
MeSH ID D009157
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Myasthenia gravis | Myasthenia gravis aggravated | Myasthenia gravis paralytica | Myasthenia Gravis | Myasthenia Gravis, Ocular | Ocular Myasthenia Gravis | Myasthenia Gravis, Generalized | Generalized Myasthenia Gravis
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01268Levobunolol hydrochloride--
BADD_D01275Levofloxacin0.000520%
BADD_D01295Linezolid0.007547%
BADD_D01303Lithium carbonate--
BADD_D01304Lithium cation--
BADD_D01305Lithium hydroxide--
BADD_D01309Lomefloxacin--
BADD_D01336Macitentan0.000577%
BADD_D01393Meropenem0.000319%
BADD_D01418Methotrexate0.000560%
BADD_D01445Metoprolol0.000078%
BADD_D01501Moxifloxacin--
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01512Nadolol--
BADD_D01587Norfloxacin--
BADD_D01598Ofloxacin--
BADD_D01616Onabotulinumtoxina--
BADD_D01653Paclitaxel0.000533%
BADD_D01709Penicillamine0.000240%
BADD_D01824Pravastatin0.000072%
BADD_D01834Prednisone0.000060%
BADD_D01835Pregabalin0.000354%
BADD_D01881Pyridostigmine0.087658%
BADD_D01895Quinine--
BADD_D01915Ranolazine0.001432%
BADD_D01951Risperidone0.001877%
BADD_D01954Rivaroxaban--
BADD_D02026Simvastatin0.000122%
BADD_D02047Sodium oxybate0.001817%
BADD_D02062Sparfloxacin--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages